Ascendiant Capital Initiates Cytori Therapeutics With Buy By: Benzinga via Benzinga May 12, 2015 at 09:15 AM EDT Ascendiant Capital initiated coverage on Cytori Therapeutics Inc (NASDAQ: CYTX) with a Buy rating. The target price for Cytori ... Read More >>